Products for Research Use Only
RegisterLogin

BI 2536 (GMP)

CAT: 0804-HY-50698GSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-50698GSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BI 2536 (GMP) is BI 2536 produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively[1]. BI-2536 suppresses IFNB (encoding IFN-β) gene transcription[4].
CAS Number
755038-02-9
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; Polo-like Kinase (PLK)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
O=C1[C@H](N(C2=C(N1C)C=NC(NC3=CC=C(C(NC4CCN(C)CC4)=O)C=C3OC)=N2)C5CCCC5)CC
Molecular Formula
C28H39N7O3
Molecular Weight
521.65
References & Citations
[1]Malik N, et al. Suppression of IFN β gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members. Biochem J. 2015 Jun 15;468 (3) :363-72.|[2]Chen L, et al. BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536. ACS Med Chem Lett. 2015 May 18;6 (7) :764-9.|[3]Steegmaier M, et al. BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo. Current Biology (2007), 17 (4), 316-322.|[4]Lénárt P, et al. The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1. Curr Biol. 2007 Feb 20;17 (4) :304-15.
Shipping Conditions
Room temperature
Scientific Category
GMP Small Molecules
Clinical Information
No Development Reported

Related Products

CatalogName
HY-50698-01BI 2536
HY-112282BI-1408
HY-P991488-01BI-765423
HY-P991192-01BI-1808
HY-123800-01BI 187004
HY-111925-01BI-749327
HY-124772-01BI-2545
HY-126253-01BI-4916
HY-124063-01BI-1935
HY-108705-01BI-3802

Alternative Products

CatalogName
200493BI-2536
442672-01BI 2536

Popular Products